We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.12%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.13B
AUM Growth
+$460M
Cap. Flow
+$219M
Cap. Flow %
10.3%
Top 10 Hldgs %
40.03%
Holding
90
New
27
Increased
17
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$32.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$23.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$19.8M
4
DXCM icon
DexCom
DXCM
+$19.6M
5
WST icon
West Pharmaceutical
WST
+$18.9M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$41.2M
2
INBX
Inhibrx, Inc. Common Stock
INBX
+$17.9M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$14.2M
4
ROIV icon
Roivant Sciences
ROIV
+$13.6M
5
SANA icon
Sana Biotechnology
SANA
+$9.05M

Sector Composition

Rank Sector Weight
1 Healthcare 90.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.07T
$232M 10.92%
298,643
– –
CYTK icon
2
Cytokinetics
CYTK
$11B
$123M 5.79%
1,757,192
– –
MRK icon
3
Merck
MRK
$324B
$78.7M 3.7%
596,261
– –
ABBV icon
4
AbbVie
ABBV
$458B
$73.5M 3.46%
403,861
-3,152
-0.8% -$543K
EW icon
5
Edwards Lifesciences
EW
$47.6B
$70.7M 3.33%
740,260
– –
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$121B
$62.2M 2.93%
148,852
– –
THC icon
7
Tenet Healthcare
THC
$20.1B
$62M 2.91%
589,409
– –
MCK icon
8
McKesson
MCK
$98.5B
$52.3M 2.46%
97,498
– –
TLT icon
9
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$49.5M 2.33%
+523,000
New +$49.5M
CNC icon
10
Centene
CNC
$31.3B
$47M 2.21%
598,513
+40,762
+7% +$3.15M
ISRG icon
11
Intuitive Surgical
ISRG
$121B
$44.3M 2.08%
111,037
+86,730
+357% +$32.8M
HUM icon
12
Humana
HUM
$46.7B
$43.5M 2.04%
125,340
– –
BDX icon
13
Becton Dickinson
BDX
$43.1B
$42.5M 2%
171,552
-28,489
-14% -$6.82M
HCA icon
14
HCA Healthcare
HCA
$84.8B
$41.6M 1.96%
124,840
– –
LEGN icon
15
Legend Biotech
LEGN
$4.3B
$41.2M 1.94%
734,293
+55,217
+8% +$3.33M
ZBH icon
16
Zimmer Biomet
ZBH
$17.7B
$39.6M 1.86%
300,351
+187,695
+167% +$23.4M
UHS icon
17
Universal Health Services
UHS
$9.43B
$39M 1.84%
213,983
+11,691
+6% +$1.93M
ICLR icon
18
Icon
ICLR
$12.8B
$38.9M 1.83%
115,726
+13,914
+14% +$4.1M
AXSM icon
19
Axsome Therapeutics
AXSM
$12.4B
$37.3M 1.75%
467,427
– –
PEN icon
20
Penumbra
PEN
$12.5B
$34.8M 1.63%
155,786
– –
AVTR icon
21
Avantor
AVTR
$7.81B
$34.3M 1.61%
1,343,309
+666,571
+98% +$15.9M
ARGX icon
22
argenx
ARGX
$57.4B
$34.2M 1.61%
86,832
– –
TMO icon
23
Thermo Fisher Scientific
TMO
$211B
$33.7M 1.59%
58,038
+6,710
+13% +$3.77M
CRBU icon
24
Caribou Biosciences
CRBU
$156M
$33.3M 1.57%
6,483,270
+2,506
+0% +$15.5K
DHR icon
25
Danaher
DHR
$135B
$31.3M 1.47%
125,515
– –
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q1 2024 Portfolio in Review

As of Q1 2024, PFM Health Sciences held 90 positions worth $2.13B, up 28% from $1.67B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences deployed $219M of net new capital in Q1 2024, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 97% a quarter earlier.

On the sell side, the largest reduction was Inhibrx, Inc. Common Stock, an estimated $17.9M trimmed.

  • PFM Health Sciences's largest Q1 2024 buy was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.
  • PFM Health Sciences added most to Intuitive Surgical in Q1 2024, an estimated $32.8M increase.
  • PFM Health Sciences's biggest Q1 2024 reduction was Inhibrx, Inc. Common Stock, cutting an estimated $17.9M.
  • PFM Health Sciences fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $41.2M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $2.13B portfolio in Q1 2024.
  • PFM Health Sciences opened 27 new positions and closed 3 in Q1 2024.
  • PFM Health Sciences's portfolio value rose 28% quarter-over-quarter to $2.13B.

Based on PFM Health Sciences's 13F filing for Q1 2024, filed 14 May 2024.